Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome.

Mylonas R, Beer I, Iseli C, Chong C, Pak HS, Gfeller D, Coukos G, Xenarios I, Müller M, Bassani-Sternberg M.

Mol Cell Proteomics. 2018 Dec;17(12):2347-2357. doi: 10.1074/mcp.RA118.000877. Epub 2018 Aug 31.

2.

Systematic evidence review of rates and burden of harm of intravenous admixture drug preparation errors in healthcare settings.

Hedlund N, Beer I, Hoppe-Tichy T, Trbovich P.

BMJ Open. 2017 Dec 28;7(12):e015912. doi: 10.1136/bmjopen-2017-015912. Review.

3.

Peripheral i.v. analysis (PIVA) of venous waveforms for volume assessment in patients undergoing haemodialysis.

Hocking KM, Alvis BD, Baudenbacher F, Boyer R, Brophy CM, Beer I, Eagle S.

Br J Anaesth. 2017 Dec 1;119(6):1135-1140. doi: 10.1093/bja/aex271.

4.

Primary Intravenous Set Consumption Across 3 Branded Infusion Pumps.

Hedlund N, Sarangpur S, Kayler S, OʼBrien K, Beer I.

J Infus Nurs. 2017 Jul/Aug;40(4):206-214. doi: 10.1097/NAN.0000000000000229.

5.

[PATELLOFEMORAL INSTABILITY: ANATOMY, CLINICAL EVALUATION, IMAGING AND TREATMENT].

Shohat N, Lindner D, Beer I, Agar G.

Harefuah. 2016 Nov;155(11):686-690. Review. Hebrew.

PMID:
28530074
6.

Assessing the costs of mobile voluntary counseling and testing at the work place versus facility based voluntary counseling and testing in Namibia.

de Beer I, Chani K, Feeley FG, Rinke de Wit TF, Sweeney-Bindels E, Mulongeni P.

Rural Remote Health. 2015 Oct-Dec;15(4):3357. Epub 2015 Nov 13.

7.

Ensuring Optimal Smart Pump Use Through Augmented User Interface.

Hoh T, Beer I, Krueger P.

Biomed Instrum Technol. 2015 Fall;Suppl:39-43. doi: 10.2345/0899-8205-49.s4.39. No abstract available.

PMID:
26444048
8.

Hyperglycaemia in patients with no history of diabetes presenting to Internal Medicine Departments.

Bar-Dayan Y, Beer I, Boaz M, Landau Z, Jakubowicz D, Wainstein J.

Int J Clin Pract. 2015 Nov;69(11):1289-95. doi: 10.1111/ijcp.12690. Epub 2015 Jul 14.

PMID:
26178790
9.

Prevalence and Knowledge Assessment of HIV and Non-Communicable Disease Risk Factors among Formal Sector Employees in Namibia.

Guariguata L, de Beer I, Hough R, Mulongeni P, Feeley FG, Rinke de Wit TF.

PLoS One. 2015 Jul 13;10(7):e0131737. doi: 10.1371/journal.pone.0131737. eCollection 2015.

10.

Mobile primary healthcare services and health outcomes of children in rural Namibia.

Aneni E, De Beer IH, Hanson L, Rijnen B, Brenan AT, Feeley FG.

Rural Remote Health. 2013;13(3):2380. Epub 2013 Sep 10.

11.

Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.

Lorente E, Infantes S, Barnea E, Beer I, Barriga A, García-Medel N, Lasala F, Jiménez M, Admon A, López D.

PLoS One. 2013;8(3):e59118. doi: 10.1371/journal.pone.0059118. Epub 2013 Mar 26.

12.

The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome.

Milner E, Gutter-Kapon L, Bassani-Strenberg M, Barnea E, Beer I, Admon A.

Mol Cell Proteomics. 2013 Jul;12(7):1853-64. doi: 10.1074/mcp.M112.026013. Epub 2013 Mar 28.

13.

Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy.

Infantes S, Lorente E, Barnea E, Beer I, Barriga A, Lasala F, Jiménez M, Admon A, López D.

J Biol Chem. 2013 Apr 12;288(15):10882-9. doi: 10.1074/jbc.M113.455352. Epub 2013 Feb 19.

14.

A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.

Lorente E, Infantes S, Abia D, Barnea E, Beer I, García R, Lasala F, Jiménez M, Mir C, Morreale A, Admon A, López D.

J Biol Chem. 2012 Oct 12;287(42):34895-903. doi: 10.1074/jbc.M112.362293. Epub 2012 Aug 27.

15.

Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities.

Hendriks ME, Wit FW, Roos MT, Brewster LM, Akande TM, de Beer IH, Mfinanga SG, Kahwa AM, Gatongi P, Van Rooy G, Janssens W, Lammers J, Kramer B, Bonfrer I, Gaeb E, van der Gaag J, Rinke de Wit TF, Lange JM, Schultsz C.

PLoS One. 2012;7(3):e32638. doi: 10.1371/journal.pone.0032638. Epub 2012 Mar 12.

16.

University students and HIV in Namibia: an HIV prevalence survey and a knowledge and attitude survey.

de Beer IH, Gelderblom HC, Schellekens O, Gaeb E, van Rooy G, McNally A, Wit FW, Tobias RWF.

J Int AIDS Soc. 2012 Feb 22;15(1):9. doi: 10.1186/1758-2652-15-9.

17.

Diabetes, HIV and other health determinants associated with absenteeism among formal sector workers in Namibia.

Guariguata L, de Beer I, Hough R, Bindels E, Weimers-Maasdorp D, Feeley FG 3rd, de Wit TF.

BMC Public Health. 2012 Jan 18;12:44. doi: 10.1186/1471-2458-12-44.

18.

Hypercalcaemia due to parathyroid carcinoma presenting in the third trimester of pregnancy.

Paul RG, Elston MS, Gill AJ, Marsh D, Beer I, Wolmarans L, Conaglen JV, Meyer-Rochow GY.

Aust N Z J Obstet Gynaecol. 2012 Apr;52(2):204-7. doi: 10.1111/j.1479-828X.2011.01391.x. Epub 2011 Dec 20.

PMID:
22188427
19.

Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.

Lorente E, Infantes S, Barnea E, Beer I, García R, Lasala F, Jiménez M, Vilches C, Lemonnier FA, Admon A, López D.

J Virol. 2012 Jan;86(1):527-41. doi: 10.1128/JVI.05737-11. Epub 2011 Oct 26.

20.

Incidence of HIV in Windhoek, Namibia: demographic and socio-economic associations.

Aulagnier M, Janssens W, De Beer I, van Rooy G, Gaeb E, Hesp C, van der Gaag J, Rinke de Wit TF.

PLoS One. 2011;6(10):e25860. doi: 10.1371/journal.pone.0025860. Epub 2011 Oct 4.

21.

TAP-independent human histocompatibility complex-Cw1 antigen processing of an HIV envelope protein conserved peptide.

Lorente E, Infantes S, Barnea E, Beer I, García R, Lasala F, Jiménez M, Admon A, López D.

AIDS. 2011 Jan 14;25(2):265-9. doi: 10.1097/QAD.0b013e328340fe3c.

PMID:
21099670
22.

Estimating HIV prevalence. A cautious note on household surveys in poor settings.

Janssens W, de Beer I, Coutinho HM, van Rooy G, van der Gaag J, Rinke de Wit TF.

BMJ. 2010 Nov 16;341:c6323. doi: 10.1136/bmj.c6323. No abstract available.

PMID:
21081608
23.

Soluble plasma HLA peptidome as a potential source for cancer biomarkers.

Bassani-Sternberg M, Barnea E, Beer I, Avivi I, Katz T, Admon A.

Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18769-76. doi: 10.1073/pnas.1008501107. Epub 2010 Oct 25.

24.

Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis.

Ulrich M, Beer I, Braitmaier P, Dierkes M, Kummer F, Krismer B, Schumacher U, Gräpler-Mainka U, Riethmüller J, Jensen PØ, Bjarnsholt T, Høiby N, Bellon G, Döring G.

Thorax. 2010 Nov;65(11):978-84. doi: 10.1136/thx.2010.137745. Epub 2010 Sep 29.

PMID:
20880875
25.

The HLA-B*2705 peptidome.

Ben Dror L, Barnea E, Beer I, Mann M, Admon A.

Arthritis Rheum. 2010 Feb;62(2):420-9. doi: 10.1002/art.27257.

26.

Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells.

Infantes S, Lorente E, Barnea E, Beer I, Cragnolini JJ, García R, Lasala F, Jiménez M, Admon A, López D.

Mol Cell Proteomics. 2010 Jul;9(7):1533-9. doi: 10.1074/mcp.M900508-MCP200. Epub 2010 Jan 15.

27.

Anonymous HIV workplace surveys as an advocacy tool for affordable private health insurance in Namibia.

de Beer I, Coutinho HM, van Wyk PJ, Gaeb E, de Wit TR, van Vugt M.

J Int AIDS Soc. 2009 Nov 11;12:32. doi: 10.1186/1758-2652-12-32.

28.

Innovation in Namibia: preserving private health insurance and HIV/AIDS treatment.

Schellekens OP, de Beer I, Lindner ME, van Vugt M, Schellekens P, Rinke de Wit TF.

Health Aff (Millwood). 2009 Nov-Dec;28(6):1799-806. doi: 10.1377/hlthaff.28.6.1799. Erratum in: Health Aff (Millwood). 2010 Jan-Feb;29(1):223. de Wit, Tobias F Rinke [corrected to Rinke de Wit, Tobias F].

PMID:
19887421
29.

Diagnostic accuracy of 2 oral fluid-based tests for HIV surveillance in Namibia.

Hamers RL, de Beer IH, Kaura H, van Vugt M, Caparos L, Rinke de Wit TF.

J Acquir Immune Defic Syndr. 2008 May 1;48(1):116-8. doi: 10.1097/QAI.0b013e31816bcdcf. No abstract available.

PMID:
18438181
30.

A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units.

Sogayar AM, Machado FR, Rea-Neto A, Dornas A, Grion CM, Lobo SM, Tura BR, Silva CL, Cal RG, Beer I, Michels V, Safi J, Kayath M, Silva E; Costs Study Group - Latin American Sepsis Institute.

Pharmacoeconomics. 2008;26(5):425-34.

PMID:
18429658
31.

Comparative proteomics of small cell lung carcinoma.

Ziv T, Barnea E, Segal H, Sharon R, Beer I, Admon A.

Cancer Biomark. 2006;2(6):219-34.

PMID:
17264394
32.

Doctors awareness of spontaneous subarachnoid haemorrhage as a cause of cardiopulmonary arrest.

Noritomi DT, de Cleva R, Beer I, Dalbem AG, Libório AB, Frota NA, Gama-Rodrigues JJ.

Resuscitation. 2006 Oct;71(1):123-4. Epub 2006 Aug 30. No abstract available.

PMID:
16942828
33.

The turnover kinetics of major histocompatibility complex peptides of human cancer cells.

Milner E, Barnea E, Beer I, Admon A.

Mol Cell Proteomics. 2006 Feb;5(2):357-65. Epub 2005 Nov 4.

34.

Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.

Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, Apweiler R, Haab BB, Simpson RJ, Eddes JS, Kapp EA, Moritz RL, Chan DW, Rai AJ, Admon A, Aebersold R, Eng J, Hancock WS, Hefta SA, Meyer H, Paik YK, Yoo JS, Ping P, Pounds J, Adkins J, Qian X, Wang R, Wasinger V, Wu CY, Zhao X, Zeng R, Archakov A, Tsugita A, Beer I, Pandey A, Pisano M, Andrews P, Tammen H, Speicher DW, Hanash SM.

Proteomics. 2005 Aug;5(13):3226-45.

35.

Centralized data analysis of a large interlaboratory proteomics project: a feasibility study.

Beer I, Barnea E, Admon A.

Proteomics. 2005 Aug;5(13):3491-6.

PMID:
16052626
36.

Evaluation of prefractionation methods as a preparatory step for multidimensional based chromatography of serum proteins.

Barnea E, Sorkin R, Ziv T, Beer I, Admon A.

Proteomics. 2005 Aug;5(13):3367-75.

PMID:
16047308
37.

Multiple brain abscesses due to Penicillium spp infection.

Noritomi DT, Bub GL, Beer I, da Silva AS, de Cleva R, Gama-Rodrigues JJ.

Rev Inst Med Trop Sao Paulo. 2005 May-Jun;47(3):167-70. Epub 2005 Jul 12.

38.

Subcompartmental intra abdominal hypertension.

Gianini F, de Cleva R, Beer I, Noritomi D, Gama-Rodrigues JJ.

Intensive Care Med. 2005 Jul;31(7):1005. Epub 2005 Jun 7. No abstract available.

PMID:
15940459
39.
40.

Hepatitis A outbreak associated with a Mothers' Day 'Yum Cha' meal, Sydney, 1997.

Lee D, Ashwell M, Ferson M, Beer I, McAnulty J.

N S W Public Health Bull. 2004 Jan-Feb;15(1-2):6-9. No abstract available.

41.

Improving large-scale proteomics by clustering of mass spectrometry data.

Beer I, Barnea E, Ziv T, Admon A.

Proteomics. 2004 Apr;4(4):950-60.

PMID:
15048977
42.

[Recombinant human activated protein C for sepsis: When should it be indicated?].

Beer I.

Rev Assoc Med Bras (1992). 2003 Jul-Sep;49(3):232-3. Epub 2003 Nov 5. Portuguese. No abstract available.

43.

Large-scale analysis of HLA peptides presented by HLA-Cw4.

Buchsbaum S, Barnea E, Dassau L, Beer I, Milner E, Admon A.

Immunogenetics. 2003 Jun;55(3):172-176. doi: 10.1007/s00251-003-0570-0. Epub 2003 May 16.

PMID:
12750860
44.

[Should fiber gastroscopy be standard in preoperative examinations for cardiac surgery?].

Vrsanský D, Valach B, Beer I, Pekar F.

Rozhl Chir. 2003 Mar;82(3):170-6. Slovak.

PMID:
12728568
45.

[Intrapericardial rupture of the inferior vena cava caused by blunt trauma].

Beer I, Bielik E, Kollárik V.

Rozhl Chir. 2002 Aug;81(8):398-400. Slovak.

PMID:
12238258
46.

Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens.

Barnea E, Beer I, Patoka R, Ziv T, Kessler O, Tzehoval E, Eisenbach L, Zavazava N, Admon A.

Eur J Immunol. 2002 Jan;32(1):213-22.

47.

Lead poisoning from drinking Kombucha tea brewed in a ceramic pot.

Phan TG, Estell J, Duggin G, Beer I, Smith D, Ferson MJ.

Med J Aust. 1998 Dec 7-21;169(11-12):644-6.

PMID:
9887919
48.

[Main variations of the extrahepatic biliary system and their application to the so-called "split-liver" transplantation technique].

Chaib E, Bertevello P, Pinto FC, Ferreira CE, Nagahama CI, Cahali RB, Beer I, Perini MV, Xavier AC, Costa LJ.

Rev Hosp Clin Fac Med Sao Paulo. 1995 Nov-Dec;50(6):311-3. Portuguese.

PMID:
8731250
49.

Attitudes to specialist recertification: results of a national survey among pathologists.

Delahunt B, Beer ID, Taylor DE.

N Z Med J. 1992 Dec 9;105(947):493-5.

PMID:
1461607
50.

Rugby injuries.

Beer I.

BMJ. 1991 Dec 14;303(6816):1552. No abstract available.

Supplemental Content

Support Center